263 related articles for article (PubMed ID: 10857385)
1. Pharmacology of appetite suppression.
Halford JC; Blundell JE
Prog Drug Res; 2000; 54():25-58. PubMed ID: 10857385
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of appetite suppression: implication for the treatment of obesity.
Halford JC
Curr Drug Targets; 2001 Dec; 2(4):353-70. PubMed ID: 11732637
[TBL] [Abstract][Full Text] [Related]
3. Separate systems for serotonin and leptin in appetite control.
Halford JC; Blundell JE
Ann Med; 2000 Apr; 32(3):222-32. PubMed ID: 10821329
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology of human appetite expression.
Halford JC; Cooper GD; Dovey TM
Curr Drug Targets; 2004 Apr; 5(3):221-40. PubMed ID: 15058309
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological approaches to appetite suppression.
Blundell J
Trends Pharmacol Sci; 1991 Apr; 12(4):147-57. PubMed ID: 2063481
[TBL] [Abstract][Full Text] [Related]
6. Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite.
Rodgers RJ; Holch P; Tallett AJ
Pharmacol Biochem Behav; 2010 Nov; 97(1):3-14. PubMed ID: 20214921
[TBL] [Abstract][Full Text] [Related]
7. Afferent signals regulating food intake.
Bray GA
Proc Nutr Soc; 2000 Aug; 59(3):373-84. PubMed ID: 10997653
[TBL] [Abstract][Full Text] [Related]
8. Neuropharmacology of human appetite expression.
Halford JC; Harrold JA
Dev Disabil Res Rev; 2008; 14(2):158-64. PubMed ID: 18646016
[TBL] [Abstract][Full Text] [Related]
9. The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box.
Williams G; Harrold JA; Cutler DJ
Proc Nutr Soc; 2000 Aug; 59(3):385-96. PubMed ID: 10997654
[TBL] [Abstract][Full Text] [Related]
10. Role of neuropeptides in appetite regulation and obesity--a review.
Arora S; Anubhuti
Neuropeptides; 2006 Dec; 40(6):375-401. PubMed ID: 16935329
[TBL] [Abstract][Full Text] [Related]
11. Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity.
Halford JC; Harrold JA; Lawton CL; Blundell JE
Curr Drug Targets; 2005 Mar; 6(2):201-13. PubMed ID: 15777190
[TBL] [Abstract][Full Text] [Related]
12. Seasonal regulation of food intake and body weight in the male Siberian hamster: studies of hypothalamic orexin (hypocretin), neuropeptide Y (NPY) and pro-opiomelanocortin (POMC).
Reddy AB; Cronin AS; Ford H; Ebling FJ
Eur J Neurosci; 1999 Sep; 11(9):3255-64. PubMed ID: 10510189
[TBL] [Abstract][Full Text] [Related]
13. Leptin signaling, adiposity, and energy balance.
Jéquier E
Ann N Y Acad Sci; 2002 Jun; 967():379-88. PubMed ID: 12079865
[TBL] [Abstract][Full Text] [Related]
14. Neuro-hormonal control of food intake: basic mechanisms and clinical implications.
Konturek PC; Konturek JW; Cześnikiewicz-Guzik M; Brzozowski T; Sito E; Konturek SJ
J Physiol Pharmacol; 2005 Dec; 56 Suppl 6():5-25. PubMed ID: 16340035
[TBL] [Abstract][Full Text] [Related]
15. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP
Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
[TBL] [Abstract][Full Text] [Related]
16. Role of leptin in the control of feeding of goldfish Carassius auratus: interactions with cholecystokinin, neuropeptide Y and orexin A, and modulation by fasting.
Volkoff H; Eykelbosh AJ; Peter RE
Brain Res; 2003 May; 972(1-2):90-109. PubMed ID: 12711082
[TBL] [Abstract][Full Text] [Related]
17. 5-HT(2C) receptor agonists and the control of appetite.
Halford JC; Harrold JA
Handb Exp Pharmacol; 2012; (209):349-56. PubMed ID: 22249823
[TBL] [Abstract][Full Text] [Related]
18. The development of tolerance to drugs that suppress food intake.
Fernstrom JD; Choi S
Pharmacol Ther; 2008 Jan; 117(1):105-22. PubMed ID: 17950459
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological aspects of appetite: implications for the treatment of obesity.
Blundell JE; Greenough A
Biomed Pharmacother; 1994; 48(3-4):119-25. PubMed ID: 7993976
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
